Skip to main content
. 2017 May 3;8(34):57642–57653. doi: 10.18632/oncotarget.17588

Table 1. Regression, recurrence and live birth rate of hysteroscopic resection (HR) and oral progestogens (p).

Number of studies Test for Heterogeneity (I2) Test for Heterogeneity: (tau-squared) Fixed effect model (effect size, 95% CI) Random effects model (effect size, 95% CI) P value
Regression rate < 0.0001
 In HR 6 62.3% 0.0210 0.9682 [0.9237; 0.9938] 0.9806 [0.9032; 1.0000]
 In P 45 62.7% < 0.0001 0.7712 [0.7454; 0.7960] 0.7720 [0.7258; 0.8151]
Recurrence rate 0.0004
 In HR 6 62% 0.0221 0.0709 [0.0272; 0.1330] 0.0479 [0.0016; 0.1523]
 In P 39 76.5% < 0.0001 0.3029 [0.2708; 0.3359] 0.3217 [0.2506; 0.3971]
Live birth rate 0.0944
 In HR 6 79.4% 0.0002 0.4928 [0.3689; 0.6172] 0.5257 [0.2466; 0.7964]
 In P 37 66.9% < 0.0001 0.3464 [0.3096; 0.3842] 0.3338 [0.2670; 0.4042]